The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of polygenic risk score for clinically significant prostate cancer in a screening program: The BARCODE 1 study results.
 
Ros A. Eeles
Stock and Other Ownership Interests - St. James's Place; The Royal Marsden NHS Foundation Trust
Honoraria - ASCO; Dana-Farber Cancer Institute; Janssen; Movember Foundation; University of Chicago
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bayer
Research Funding - Novo Nordisk (Inst)
Patents, Royalties, Other Intellectual Property - Cancer Research Technology
 
Elizabeth Kathryn Bancroft
No Relationships to Disclose
 
Jana Kathlyn McHugh
No Relationships to Disclose
 
Edward Saunders
No Relationships to Disclose
 
Mark Brook
No Relationships to Disclose
 
Eva McGrowder
No Relationships to Disclose
 
Sarah Wakerell
No Relationships to Disclose
 
Denzil James
No Relationships to Disclose
 
Elizabeth Page
No Relationships to Disclose
 
Andrea Osborne
No Relationships to Disclose
 
Netty Kinsella
No Relationships to Disclose
 
Syed Aslam Sohaib
No Relationships to Disclose
 
Declan Cahill
No Relationships to Disclose
 
Stephen Hazell
No Relationships to Disclose
 
Sam Withey
No Relationships to Disclose
 
Imran Rafi
No Relationships to Disclose
 
Pardeep Kumar
No Relationships to Disclose
 
Nicholas D. James
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Janssen Oncology; Merck; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen; Sanofi
 
Sarah Benafif
No Relationships to Disclose
 
Zsofia Kote-Jarai
Research Funding - Cancer Research Technology